Inventor
Dennis E. Hruby
Inventor
Albany, OR, US
Overview
Patents· 49 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds19%
Y02ATechnologies for adaptation to climate change10%
C07CAcyclic or carbocyclic compounds8%
C12NMicroorganisms or enzymes4%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
C07BGeneral methods of organic chemistry3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,933,050Polymorphic forms of ST-246 and methods of preparation202110,864,282ST-246 liquid formulations and methods202010,716,759Rehydration of micronized tecovirimat monohydrate202010,576,165ST-246 liquid formulations and methods202010,406,137Polymorphic forms of ST-246 and methods of preparation201910,406,103Rehydration of micronized tecovirmimat monohydrate201910,124,071ST-246 liquid formulations and methods201810,045,963Amorphous Tecovirimat preparation201810,045,964Polymorphic forms of ST-246 and methods of preparation201810,000,486Antiviral drugs for treatment of arenavirus infection20189,968,571Inhibitors and methods of inhibiting bacterial and viral pathogens20189,907,859'ST-246 liquid formulations and methods'20189,889,119'Amorphous tecovirimat preparation'20189,744,154'Polymorphic forms of ST-246 and methods of preparation'20179,670,158'Amorphous tecovirimat preparation'20179,566,254'Inhibitors and methods of inhibiting bacterial and viral pathogens'20179,498,470'Antiviral drugs for treatment of arenavirus infection'20169,353,051'Antiviral drugs for treatment or prevention of dengue infection'20169,339,466'Polymorphic forms of ST-246 and methods of preparation'20169,301,949'Thienopyridine derivatives for the treatment and prevention of dengue virus infections'20169,233,087'Inhibitors and methods of inhibiting bacterial and viral pathogens'20169,233,097'ST-246 liquid formulations'20169,199,920'Antiviral drugs for treatment of arenavirus infection'20159,115,065'Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses'20159,096,597'Antiviral drugs for treatment of Arenavirus infection'20159,029,376'Small molecule inhibitors for the treatment or prevention of dengue virus infection'20158,993,604'Treatment and prevention of dengue virus infections'20158,871,746'Antiviral drugs for treatment of arenavirus infection'20148,791,110'Anti-arenaviral compounds'20148,754,082'Antiviral drugs for treatment of Arenavirus infection'20148,664,274'Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses'20148,658,697'Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses'20148,629,170'Anti-viral drugs for treatment of arenavirus infection'20148,623,347'Antiviral drugs for treatment of arenavirus infection'20148,518,960'Antiviral drugs for treatment or prevention of dengue infection'20138,518,951'Anti-arenaviral compounds'20138,492,434'Antiviral drugs for treatment of arenavirus infection'20138,461,177'Antiviral drugs for treatment of arenavirus infection'20138,410,149'Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses'20138,148,428'Antiviral drugs for treatment of arenavirus infection'20128,106,058'Anti-arenaviral compounds'20127,994,221'Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses'20117,977,365'Antiviral drugs for treatment of arenavirus infection'20117,872,037'Antiviral drugs for treatment of arenavirus infection'20117,067,248'Screening method for orthopoxvirus antivirals'20066,312,955'Streptococcus gordonii strains resistant to fluorodeoxyuridine'20016,306,619'DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function'20015,985,654'Recombinant poxvirus and streptococcal M protein vaccine'19995,821,088'Use of gram-positive bacteria to express recombinant proteins'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998Based in Redding, CT, US· patent location history
1999Based in Corvallis, OR, US· patent location history
2001–2021Based in Albany, OR, US· patent location history
2006–2016Patents assigned to SIGA TECHNOLOGIES INC (24)· patent assignee history
2012–2016Patents assigned to HRUBY DENNIS E (20)· patent assignee history
2012–2016Patents assigned to DAI DONGCHENG (18)· patent assignee history
2013–2016Patents assigned to AMBERG SEAN M (8)· patent assignee history
2017–2021Patents assigned to SIGA TECH INC (15)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGA TECHNOLOGIES INC | 24 | 2006–2016 |
| HRUBY DENNIS Eself | 20 | 2012–2016 |
| DAI DONGCHENG | 18 | 2012–2016 |
| SIGA TECH INC | 15 | 2017–2021 |
| AMBERG SEAN M | 8 | 2013–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Albany, OR, US | 47 | 2001–2021 |
| Corvallis, OR, US | 1 | 1999 |
| Redding, CT, US | 1 | 1998 |